NASDAQ:PTEIQ PolarityTE (PTEIQ) Stock Price, News & Analysis → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free PTEIQ Stock Alerts $0.07 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.02▼$0.0750-Day Range$0.02▼$0.1052-Week Range$0.05▼$0.09Volume457 shsAverage Volume27,292 shsMarket Capitalization$511,668.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsSEC FilingsSocial Media Get PolarityTE alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About PolarityTEPolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.Read More PTEIQ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PTEIQ Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive PTEIQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PolarityTE and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:PTEIQ CUSIPN/A CIK1076682 Webwww.polarityte.com Phone(800) 560-3983Fax302-636-5454Employees42Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.28) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,830,000.00 Net MarginsN/A Pretax Margin-11,376.71% Return on Equity-106.08% Return on Assets-76.91% Debt Debt-to-Equity RatioN/A Current Ratio4.11 Quick Ratio4.11 Sales & Book Value Annual Sales$810,000.00 Price / Sales0.63 Cash FlowN/A Price / Cash FlowN/A Book Value$2.30 per share Price / Book0.03Miscellaneous Outstanding Shares7,320,000Free Float6,988,000Market Cap$511,668.00 OptionableNot Optionable Beta0.92 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Richard Hague (Age 63)Pres & CEO Comp: $479.81kMr. Jacob Alexander Patterson (Age 44)Chief Financial Officer Comp: $262.85kMr. Nikolai SopkoChief Scientific Officer and VP of R&DMr. Rich HaerleVP of Investor Relations & StrategyMr. Mark E. Lehman J.D.Chief Legal OfficerAngela ZieglerVP of Marketing & PRMr. Alain AdamVP of SalesDr. Jon Anthony Joseph Burrows B.Sc. (Age 60)M.Sc., Ph.D., Sr. VP of Corp. Devel. & Pres of Contract Services Mr. Ryan Mathis M.D.Chief Medical OfficerMr. Kolby Day Esq.Sr. VP of Manufacturing OperationsMore ExecutivesKey CompetitorsPeak BioNASDAQ:PKBOObsEvaNASDAQ:OBSVCalithera BiosciencesNASDAQ:CALAScopus BioPharmaNASDAQ:SCPSIgnyte AcquisitionNASDAQ:IGNYView All Competitors PTEIQ Stock Analysis - Frequently Asked Questions How have PTEIQ shares performed in 2024? PolarityTE's stock was trading at $0.0840 at the start of the year. Since then, PTEIQ stock has decreased by 16.8% and is now trading at $0.0699. View the best growth stocks for 2024 here. How do I buy shares of PolarityTE? Shares of PTEIQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PTEIQ) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PolarityTE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
